Daniel P. Menard
Plus aucun poste en cours
Profil
Daniel P.
Menard is President and Chief Operating Officer of Algos Therapeutics, Inc. He joined MDS Pharma Services in 2001 and served as Vice President and General Manager.
Dr. Menard joined AstraZeneca Montreal as a Research.
He has over 15 years of industrial and academic drug development experience.
Anciens postes connus de Daniel P. Menard
| Sociétés | Poste | Fin |
|---|---|---|
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
MDS Pharma Services (Canada)
 MDS Pharma Services (Canada) Miscellaneous Commercial ServicesCommercial Services MDS Pharma Services provides contract drug discovery and drug development services for pharmaceutical and biotechnology companies. It provides its clients with early-stage, clinical research and late-stage drug discovery and development services, such as Phase I-IV testing, target discovery and lead optimization. The company is located in Saint-Laurent, Canada. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
MDS Pharma Services (Canada)
MDS Pharma Services (Canada) Miscellaneous Commercial ServicesCommercial Services MDS Pharma Services provides contract drug discovery and drug development services for pharmaceutical and biotechnology companies. It provides its clients with early-stage, clinical research and late-stage drug discovery and development services, such as Phase I-IV testing, target discovery and lead optimization. The company is located in Saint-Laurent, Canada. | Commercial Services |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Health Technology |
